Revised SPC: Rebrikel (buprenorphine) transdermal patches – all strengths

SPC updated to include caution for sleep-related breathing disorders including sleep-related hypoxemia and central sleep apnoea (CSA) with recommendation to decrease total opioid dosage in patients who present with CSA and application skin discolouration added as side effect.

Source:

electronic Medicines compendium